Fig. 2 (abstract P192).
From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Pathology of stomach and duodenum post vedolizumab
Fig. 2 (abstract P192). | Journal for ImmunoTherapy of Cancer